Ben Lawrence

2.2k citations

47 papers · 1.2k indexed · 1 hit paper · h-index 15

Impact in

Neurology top 2%
- Neuroblastoma Research and Treatments
Oncology top 5%
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research

Papers in ⓘ

Oncology 31
- Lung Cancer Research Studies 22
- Pancreatic and Hepatic Oncology Research 11
- Polyomavirus and related diseases 3
Epidemiology 30
- Neuroendocrine Tumor Research Advances 30

Co-authors: Mark Kidd (17 shared papers)Irvin M. Modlin (15 shared papers)Bernhard Svejda (8 shared papers)Björn Gustafsson (4 shared papers)Anthony Chan (2 shared papers)Simon Schimmack (11 shared papers)Roswitha Pfragner (4 shared papers)Daniele Alaimo (6 shared papers)
Journals: Cancer (2 papers)Endocrinology and Metabolism Clinics of North America (2 papers)Neuroendocrinology (2 papers)Langenbeck s Archives of Surgery (2 papers)Gastroenterology (2 papers)
Partner nations: New Zealand United States Germany

In The Last Decade

Ben Lawrence

43 papers receiving 1.2k citations

Hit Papers

align trajectories log scale

The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors 2011 · 632 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2011 Endocrinology and Metabolism Clinics of North America

Peers

Countries citing papers authored by Ben Lawrence

Since Specialization

Citations

This map shows the geographic impact of Ben Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Lawrence more than expected).

Fields of papers citing papers by Ben Lawrence

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Lawrence. The network helps show where Ben Lawrence may publish in the future.

Co-authors

The 25 scholars most cited alongside Ben Lawrence, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ben Lawrence Line = papers co-authored together Ben Lawrence links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors Endocrinology and Metabolism Clinics of North America ·Ben Lawrence, Björn Gustafsson, Anthony Chan, Bernhard Svejda, Mark Kidd, Irvin M. Modlin Hit paper breakdown →	2011	632
2	The Clinical Relevance of Chromogranin A as a Biomarker for Gastroenteropancreatic Neuroendocrine Tumors Endocrinology and Metabolism Clinics of North America ·Ben Lawrence, Björn Gustafsson, Mark Kidd, (unknown), Bernhard Svejda, Irvin M. Modlin	2011	117
3	Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor–mediated PI3K feedback loop activation via ERK1/2 and AKT Cancer ·Bernhard Svejda, Mark Kidd, Alexander D. Kazberouk, Ben Lawrence, Roswitha Pfragner, Irvin M. Modlin	2011	68
4	A mechanistic role for the chromatin modulator, NAP1L1, in pancreatic neuroendocrine neoplasm proliferation and metastases Epigenetics & Chromatin ·Simon Schimmack, Andrew Taylor, Ben Lawrence, Daniele Alaimo, Hubertus Schmitz‐Winnenthal, Markus W. Büchler, Irvin M. Modlin, Mark Kidd	2014	44
5	Serotonin and the 5‐HT7 receptor: The link between hepatocytes, IGF‐1 and small intestinal neuroendocrine tumors Cancer Science ·Bernhard Svejda, Mark Kidd, Andrew T. Timberlake, Kathy Harry, Alexander D. Kazberouk, Simon Schimmack, Ben Lawrence, Roswitha Pfragner, Irvin M. Modlin	2013	34
6	EGFR/TGFα and TGFβ/CTGF Signaling in Neuroendocrine Neoplasia: Theoretical Therapeutic Targets Neuroendocrinology ·Mark Kidd, Simon Schimmack, Ben Lawrence, Daniele Alaimo, Irvin M. Modlin	2012	28
7	The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant Langenbeck s Archives of Surgery ·Irvin M. Modlin, Steven F. Moss, Björn Gustafsson, Ben Lawrence, Simon Schimmack, Mark Kidd	2011	28
8	A Clinical Perspective on Gastric Neuroendocrine Neoplasia Current Gastroenterology Reports ·Ben Lawrence, Mark Kidd, Bernhard Svejda, Irvin M. Modlin	2010	26
9	Quality of life is not influenced by the extent of surgery in patients with benign goiter Langenbeck s Archives of Surgery ·Friedrich H. Schmitz-Winnenthal, Simon Schimmack, Ben Lawrence, Uwe Maier, Miriam Heidmann, Markus W. Büchler, Moritz von Frankenberg	2011	25
10	Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signaling Tumor Biology ·Simon Schimmack, Andrew Taylor, Ben Lawrence, Hubertus Schmitz‐Winnenthal, Lars Fischer, Markus W. Büchler, Irvin M. Modlin, Mark Kidd, Laura H. Tang	2014	20
11	Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals International Journal of Cancer ·Simone Leyden, Teodora Kolarova, Catherine Bouvier, Martyn Caplin, Siobhan Conroy, Phillipa Davies, Sugandha Dureja, Massimo Falconi, Piero Ferollà, George A. Fisher, Grace Goldstein, Rodney J. Hicks, Ben Lawrence, Yoshiyuki Majima, David C. Metz, Dermot O’Toole, Philippe Ruszniewski, Bertram Wiedenmann, Ronald Hollander, (unknown)	2019	19
12	PDX1 DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different Prognosis Cancers ·Gitta Boons, Timon Vandamme, Joe Ibrahim, Geert Roeyen, Ann Driessen, Dieter Peeters, Ben Lawrence, Cristin G. Print, Marc Peeters, Guy Van Camp, Ken Op de Beeck	2020	18
13	The clinical implications and biologic relevance of neurofilament expression in gastroenteropancreatic neuroendocrine neoplasms Cancer ·Simon Schimmack, Ben Lawrence, Bernhard Svejda, Daniele Alaimo, Hubertus Schmitz‐Winnenthal, Lars Fischer, Markus W. Büchler, Mark Kidd, Irvin M. Modlin	2011	16
14	GNA15 expression in small intestinal neuroendocrine neoplasia: Functional and signalling pathway analyses Cellular Signalling ·Sara Zanini, Francesco Giovinazzo, Daniele Alaimo, Ben Lawrence, Roswitha Pfragner, Claudio Bassi, Irvin M. Modlin, Mark Kidd	2015	14
15	Circulating tumor DNA is a sensitive marker for routine monitoring of treatment response in advanced colorectal cancer Carcinogenesis ·Donghui Zou, Robert C. Day, Judy Ann Cocadiz, Sarah Parackal, Wilson Mitchell, Michael A. Black, Ben Lawrence, Sandra Fitzgerald, Cristin G. Print, Christopher Jackson, Parry Guilford	2020	14
16	New Pharmacologic Therapies for Gastroenteropancreatic Neuroendocrine Tumors Gastroenterology Clinics of North America ·Ben Lawrence, Bjørn I. Gustafsson, Mark Kidd, Irvin M. Modlin	2010	11
17	Management Information Systems: Their Development and Use in the Administration of Higher Education. John Minter, Ben Lawrence	1969	11
18	ANG1005: Results of a phase I study in patients with advanced solid tumors and brain metastases. Journal of Clinical Oncology ·John Sarantopoulos, N. Gabrail, Stacy L. Moulder, A. J. Brenner, Cayce Smith, D. Bouchard, Kelly Elian, Ben Lawrence, J. Castaigne, Razelle Kurzrock	2010	10
19	Minichromosome Maintenance Expression Defines Slow-Growing Gastroenteropancreatic Neuroendocrine Neoplasms Translational Oncology ·Simon Schimmack, Ben Lawrence, Barton Kenney, Hubertus Schmitz‐Winnenthal, Irvin M. Modlin, Mark Kidd	2016	8
20	Systemic therapy for metastatic pancreatic adenocarcinoma Therapeutic Advances in Medical Oncology ·Ben Lawrence, Michael Findlay	2010	7

About Ben Lawrence

Ben Lawrence is a scholar working on Oncology, Epidemiology, Neurology, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 47 papers that have together received 1.2k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (30 papers), Lung Cancer Research Studies (22 papers), Pancreatic and Hepatic Oncology Research (11 papers), Neuroblastoma Research and Treatments (9 papers), Cancer Genomics and Diagnostics (5 papers), Polyomavirus and related diseases (3 papers), Genetic factors in colorectal cancer (2 papers) and Antenna Design and Analysis (2 papers). The work is most often cited by research in Neurology (566 citations), Oncology (931 citations), Epidemiology (947 citations), Gastroenterology (64 citations) and Cancer Research (75 citations). Ben Lawrence has collaborated with scholars based in New Zealand, United States and Germany. Frequent co-authors include Mark Kidd, Irvin M. Modlin, Bernhard Svejda, Björn Gustafsson, Anthony Chan, Simon Schimmack, Roswitha Pfragner, Daniele Alaimo, Markus W. Büchler and Hubertus Schmitz‐Winnenthal. Their work appears in journals such as Cancer, Endocrinology and Metabolism Clinics of North America, Neuroendocrinology, Langenbeck s Archives of Surgery and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact